PrecisionLife
Colin Stubberfield is a seasoned professional in the pharmaceutical and biotech industries, currently serving as SVP of Drug Discovery at PrecisionLife since February 2022. In addition, Colin has held the position of Principal Scientist at e-Therapeutics PLC since 2013. Previous experience includes a decade at UCB as Director of Primary Pharmacology and a period at Oxford GlycoSciences as Director of Drug Discovery from 1998 to 2003. Colin Stubberfield brings extensive expertise in drug discovery and pharmacology to their roles.
This person is not in any offices
PrecisionLife
Our unique approach powers an Innovation Engine creating new treatment opportunities for precision biopharma and healthcare.We generate the deepest understanding of the biology driving chronic diseases, stratifying patient populations at an unprecedented resolution to define new subgroups of patients.With these insights we discover novel drugtargets, drug repositioning candidates, and biomarkers to identify the patients who will benefit from them.#techbio #precisionmedicine